Blood Type Determination
Find information on Blood Type Determination, also known as Blood Group Typing or ABO and Rh Typing. This page covers details relevant to healthcare professionals, including clinical documentation and medical coding for Blood Type Determination. Learn about the importance of accurate blood typing in medical procedures and transfusions. Understand the different blood groups (ABO and Rh) and their significance in patient care. This resource offers guidance on proper coding and documentation for Blood Type Determination for clinical settings.
Identifies a person's ABO blood group and Rh factor (positive or negative).
Usually no specific signs. Determined by blood test before transfusions, surgery, or pregnancy.
Hospitals, blood banks, clinics, doctor's offices, prenatal care settings.
ICD-10 Code Families
Complete code families applicable to Z01.83
When to use each related code
| Description | When to use |
|---|---|
| Determines ABO and Rh blood type. | Use for initial blood typing, transfusions, pregnancy, or surgical planning. |
| Identifies antibodies against red blood cell antigens. | Use for pre-transfusion testing, investigating hemolytic reactions, or pregnancy complications. |
| Screens for unexpected antibodies in donor blood. | Use for donor blood processing to ensure compatibility and prevent transfusion reactions. |
Best-practice checklist
- ✓Document reason for blood type testing (e.g., transfusion, pregnancy)
- ✓Record patient consent for the procedure.
- ✓Specify method used (e.g., tube, slide, microplate).
- ✓Clearly document ABO and Rh results (e.g., A+, O-).
- ✓Note any discrepancies or unexpected reactions.
Common pitfalls to avoid
Coding with unspecified B blood type when a more specific type (e.g., B+, B-) is documented. Impacts reimbursement and transfusion safety.
Lack of documentation supporting the medical necessity of blood typing. May lead to claim denials for medically unnecessary testing.
Separately billing for ABO and Rh typing when performed together. Correct coding requires a combined code for both tests.
Best-practice tips
- 01Document ABO/Rh testing medical necessity (ICD-10 Z04.1, Z71.818).
- 02Ensure clear order for blood type, avoid duplicate testing (CPT 86900, 86901).
- 03Validate patient identity before sample collection to prevent errors.
- 04Properly label samples with patient demographics and date/time.
- 05Follow lab protocols for blood sample handling and analysis for accuracy.
Step-by-step checklist
- 1
Verify patient identity prior to blood draw.
- 2
Confirm blood type matches previous records.
- 3
Document ABO/Rh type clearly in chart.
- 4
Review indications for blood typing.
- 5
Check for hemolysis affecting result.
Ready-to-paste narrative
Patient presented for blood type determination, also known as blood group typing or ABO and Rh typing. This procedure was medically necessary for pre-operative planning, transfusion preparation, or pregnancy management. The patient's medical history was reviewed, including any previous blood transfusions, pregnancies, and known blood-related disorders. A blood sample was collected via venipuncture following standard aseptic technique. The sample was then analyzed in a certified laboratory using commercially available reagents for ABO and Rh typing. Results of the blood typing were documented clearly and accurately in the patient's electronic health record. This information is crucial for patient safety and informs appropriate medical decision-making related to blood transfusions and other procedures. The patient understood the procedure and tolerated it well. Future medical care will be guided by these blood type results, and appropriate coding and billing will reflect this essential diagnostic service. Possible diagnostic codes include 86900, 86901, or 86905 depending on the specific testing performed.
Common questions and answers
What are the most reliable methods for blood type determination in critically ill patients when rapid and accurate results are crucial?+
In critically ill patients requiring rapid and accurate blood type determination, methods like gel card technology or solid-phase red cell adherence assays offer advantages over traditional tube testing. These methods are less prone to subjective interpretation and can be automated, reducing turnaround time and minimizing human error, especially crucial in emergency situations. While tube testing remains valuable, these newer technologies enhance efficiency and reliability in critical care settings. Consider implementing point-of-care testing options for enhanced speed in life-threatening situations. Explore how different blood typing methods compare in terms of turnaround time and accuracy for critically ill patient populations.
Beyond ABO and Rh typing, what additional blood group antigens should be considered for complex transfusion scenarios, such as multiple alloimmunized patients or those with rare blood types?+
While ABO and Rh typing are fundamental, complex transfusion scenarios like multiple alloimmunized patients or those with rare blood types necessitate considering extended blood group antigen typing. Antigens from the Kell, Duffy, Kidd, MNS, and Lewis systems are clinically significant and should be considered, particularly when patients have a history of multiple transfusions or pregnancy. Antibody screening and identification against these antigens are crucial to prevent hemolytic transfusion reactions. Learn more about the prevalence and clinical significance of different blood group systems beyond ABO and Rh to effectively manage complex transfusions. Explore implementing extended antigen matching protocols for high-risk patients to optimize transfusion safety.
How can I differentiate between ABO typing discrepancies due to weak subgroups, acquired B antigens, or other interfering factors, and what are the best practices for resolving these discrepancies?+
ABO typing discrepancies can arise from several factors, including weak subgroups (like A2 or B3), acquired B antigens (often seen in certain infections or malignancies), or interfering substances such as cold agglutinins or rouleaux formation. Resolving these discrepancies requires a systematic approach involving repeat testing with antisera from different manufacturers, testing patient serum against known A and B cells, and investigating patient history. Consider implementing adsorption techniques or using specific lectins to elucidate the cause of discrepancies. Explore how factors like patient age, underlying medical conditions, and recent transfusions can influence ABO typing results and inform your approach to discrepancy resolution.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.